BALAXI
Balaxi Pharmaceuticals Limited
Pharmaceuticals · ₹146 Cr market cap
An IPR-based pharmaceutical company engaged in the production, stocking, and distribution of branded and generic medicines across India. Balaxi Pharma manufactures a diverse portfolio of pharmaceutical products catering to various therapeutic segments and medical needs. The company distinguishes itself through its focus on developing proprietary formulations while maintaining quality standards in manufacturing, regulatory compliance, and supply chain operations across domestic markets.
1
Tracked investors holding
2
Tracked moves
₹24
Share price
Latest activity
RGSL InvestmentIncreased
RGSL Investment bought 5,22,340 shares of Balaxi Pharmaceuticals for ₹0.92 Cr at ₹17.68 apiece in a bulk deal on March 24, 2026.
Top investors holding Balaxi Pharmaceuticals Limited
2.54%
Track smart money in Balaxi Pharmaceuticals Limited
Get alerted when a top investor buys or sells.
Get started